SARAH MALIK: Open Payments
NPI 1821762121 · MIDDLETOWN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,225 in 135 payments from 14 companies in 2025. Trend: 2023 $69 · 2024 $2,595 · 2025 $2,225
Food & beverage: $2,225
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 66 | $929 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 22 | $425 |
| Supernus Pharmaceuticals, Inc. | 10 | $215 |
| Otsuka America Pharmaceutical, Inc. | 18 | $189 |
| Alkermes, Inc. | 6 | $154 |
| Teva Pharmaceuticals USA, Inc. | 2 | $58 |
| Janssen Pharmaceuticals, Inc | 2 | $56 |
| Neurocrine BioSciences, Inc. | 2 | $51 |
| Axsome Therapeutics, Inc. | 2 | $46 |
| E.R. Squibb & Sons, L.L.C. | 1 | $23 |
Products named: VRAYLAR, CAPLYTA, Qelbree, REXULTI, ARISTADA, ABILIFY MAINTENA, BOTOX, AUSTEDO XR.
Industry payments across NY — which companies pay providers there.
